Enterprise of Rosatom State Corporation
Print version

Industry news

Worldwide Medical Imaging Reagents Market on the Rise

The global market for medical reagents, including those used for molecular imaging purposes, is expected to grow substantially through 2016.

Update on Mo-99 Availability

The ongoing Molybdenum-99 (Mo-99) supply challenges faced by the nuclear medicine industry remain in effect. Based on currently available resources and projections for Mo-99 supply next month, generator standing orders should be met throughout February.

Obama Signs Omnibus; Includes $5 Million for Nuclear Medicine Research

President Obama signed H.R.3547, the Consolidated Appropriations Act, also known as the $1 trillion omnibus spending bill, into law.

Clinical Comparison of Tc-99m Exametazime and I-123 Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury

Researchers are seeking to understand what happens inside the living brain after a concussion. In a study published today in PLOS ONE, researchers at Thomas Jefferson University used SPECT to evaluate two ways to measure physiological brain activity in Traumatic Brain Injury (T.B.I.) patients.

Discerning Infection from Inflammation: a New PET/CT Technique

Antimicrobial peptide PET/CT imaging with gallium-68 appears to break through previous roadblocks in differentiating infections and sterile inflammatory processes, according to a study published in the Journal of Nuclear Medicine.

Cardiologists Continue Imaging Despite Isotope Shortage by Using Fewer Radiopharmaceuticals

As the global medical isotope shortage continues indefinitely following the plant leak in South Africa, Berks Cardiologists Ltd., a cardiovascular imaging center in central Pennsylvania, is continuing to operate at the same procedure volume and with their lower-dose cardiac nuclear medicine imaging protocols.

Isotope Production Alternatives Aim to Meet North American Demand

With the world's major producing reactors shutting down regularly or facing decommission, some enterprising solutions to medical isotope production are jockeying to pick up the slack in North America.

NorthStar Awarded $21.8 Million for Domestic Molybdenum

Northstar Medical Technologies was awarded $21.8 million in part by the U.S. Department of Energy’s National Nuclear Security Administration (NNSA).

NRC Okays U.S. Isotope Plant Construction Application

NRC has accepted the second and final portion of the company's application for a construction permit to build an accelerator plant for medical isotopes.

Molecular Imaging Device Market Expected to Rise to $3B by 2018

The current global market for molecular imaging technology is estimated at $2.2 billion this year and is expected to increase at a compound annual growth rate of 6.2 percent, according to a November 2013 market research report from BCC Research.